Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …

Hepatocellular carcinoma recurrence occurs in 40–70% of patients after hepatic resection.
Despite the high frequency of hepatocellular cancer relapse, there is no established …

The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma …

Percutaneous radiofrequency ablation (RFA) is effective for the treatment of small
hepatocellular carcinoma (HCC) with a diameter≤ 3.0 cm. The present study aimed to …

Accurate diagnosis and effective treatment of primary liver tumors are of great significance,
and optical imaging has been widely employed in clinical imaging-guided surgery for liver …

To assess the safety and clinical outcomes of multi-probe stereotactic radiofrequency
ablation (SRFA) for very large (≥ 8 cm) primary and metastatic liver tumors with curative …

Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
mortality in Taiwan. To help clinical physicians to manage patients with HCC, the Taiwan …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths
worldwide. Liver transplant is considered the gold standard for curative therapy for HCC …

Background and aims So far, no randomized trial or meta-analysis has been conducted on
overall survival (OS) and recurrence-free survival (RFS) factors in patients treated with …

Glioma is the most frequent primary brain tumour of the central nervous system. Its high
aggressiveness and deep‐seated brain lesion make it a great challenge to develop a non …